Lee Ainslie / Trevor Wiessmann
@Maverick Capital Ltd
Latest period2024 - Q3ReportedManaged Assets$5.129BTotal holdings229
Assets growth rate-2.72%Assets growth rate (2-Q avg)-1.82%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Maverick Capital Ltd's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 229 positions.
Assets under management
The assets under management (AUM) of Maverick Capital Ltd over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 5.129B in assets, with a quarterly growth rate of -2.72% and a 2-quarter average growth rate of -1.82%. The portfolio is managed by Lee Ainslie, Trevor Wiessmann, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
VRNAVerona Pharma Plc
| 2.37% | $121.294M 4.216M shares@ $28.77 avg price | Increased 36.32% |
LPLALpl Finl Hldgs Inc
| 2.26% | $115.635M 497,075 shares@ $232.63 avg price | Increased 81.99% |
PCVXVaxcyte Inc
| 2.18% | $111.556M 976,249 shares@ $114.27 avg price | Increased 41.92% |
CARTMaplebear Inc
| 2.14% | $109.363M 2.684M shares@ $40.75 avg price | Increased 19.67% |
TSMTaiwan Semiconductor Mfg Ltd
| 2.09% | $107.151M 616,979 shares@ $173.68 avg price | Increased 26.15% |
SWTXSpringworks Therapeutics Inc
| 1.74% | $89.018M 2.778M shares@ $32.05 avg price | Increased 6.84% |
WVEWave Life Sciences Ltd
| 1.61% | $82.39M 10.048M shares@ $8.2 avg price | Increased 31.01% |
RCKTRocket Pharmaceuticals Inc
| 1.49% | $76.072M 4.119M shares@ $18.48 avg price | Increased 4.85% |
NFLXNetflix Inc
| 1.42% | $72.811M 102,656 shares@ $709.27 avg price | Increased 17941.48% |
HUMHumana Inc
| 1.23% | $62.68M 197,892 shares@ $316.74 avg price | Increased 3.31% |